Loovi AB

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Loovi AB - overview

Established

2024

Location

Stockholm, -, Sweden

Primary Industry

Healthcare IT

About

Loovi AB, based in Sweden, specializes in health optimization services through medical testing, providing personalized coaching and consultations to clients focused on enhancing their wellness and performance. Loovi AB is a healthcare company that provides personalized health optimization services through medical testing. Founded in 2024 and headquartered in Stockholm, Sweden, the company has completed 1 deal as of its most recent funding on February 12, 2026, securing EUR 1 million in venture funding. The founder's history is not detailed, and there are no mentions of major pivots or subsidiary relationships.


Loovi offers a comprehensive health optimization service led by medical professionals, focusing on personalized coaching through blood analysis and fitness assessments. The core offering includes blood tests conducted at over 80 clinics, analyzing over 60 selected biomarkers related to various health metrics such as blood lipids, inflammation, and hormonal balance. Clients engage in consultations with Loovi doctors to review results and address health inquiries, culminating in a customized Action Plan that provides fitness and nutritional guidance tailored to individual health goals. The end-users of Loovi’s services primarily include health-conscious individuals and athletes seeking to enhance their performance and well-being, with operations expanding geographically.


Loovi's revenue model is subscription-based, offering regular health assessments and consultations. Clients purchase subscriptions that include biannual blood tests, personalized health plans, and ongoing support from health professionals. This structure fosters long-term relationships with users committed to health optimization while ensuring a consistent revenue stream. Pricing reflects the comprehensive nature of the offerings, which encompass blood analysis, tailored action plans, and continuous monitoring of health metrics.


In February 2026, Loovi AB raised EUR 1 million in venture funding to develop its platform and support market expansion. The company plans to launch new products aimed at enhancing its health optimization services, with specific timelines for release yet to be announced. Additionally, Loovi aims to expand into new markets, targeting regions that align with its growth strategy, although specific locations have not been disclosed.


Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Medical Software

Website

www.loovi.se/

Verticals

HealthTech

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.